A. Arduino

发表

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes

A. Piga, F. Longo, A. de Nicolò, 2017, The Pharmacogenomics Journal.

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients.

A. Piga, F. Longo, A. D’Avolio, 2017, Pharmacogenomics.

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia.

A. Piga, F. Longo, A. D’Avolio, 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.